Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
106.00Prev. Close
107.69Volume
1,68,024Total traded value
1.73 CrUpper Circuit
123.50Lower Circuit
82.33Fundamentals
| Market Cap | ₹789Cr |
| ROE | 3.14% |
| P/E Ratio(TTM) | 3.49 |
| EPS(TTM) | 30.75 |
| P/B Ratio | 0.63 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.07 |
| Book Value | 169.62 |
| Debt to Equity | 0.03 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Ind Swift Laboratories
Ind-Swift Laboratories, a prominent global pharmaceutical brand, has strategically decided to enter the business of finished medicines, also known as formulations. This strategic shift is driven by the single objective of unlocking value and strengthening its capacity for future growth and innovation. The company demonstrates a strong global reach, as more than 70% of its revenue was generated from exports to international markets.;
| Parent Organisation | Ind Swift Laboratories |
| Managing Director | Shri. Navrattan Munjal |
| NSE Symbol | INDSWFTLAB |
Shareholding Pattern
Dec '24
Mar '25
Jun '25
Jul '25
Aug '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 102.92 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.00 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.72 | ||
| Wockhardt | NA (0.00%) | -151.40 |